Targeting STATs for cancer therapy

  title={Targeting STATs for cancer therapy},
  author={David M. Frank},
We are in the midst of an exciting transition in the treatment of cancers, from the empirically developed non-specifically cytotoxic drugs to the era of rationally derived molecularly targeted therapies. Over the past 15 years, our understanding of the mutations that drive cancer pathogenesis has grown enormously, which has rapidly led to the development of… CONTINUE READING